IRadimed Corporation (IRMD)
USD 49.54
(-3.54%)
USD 49.54
(-3.54%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 30.12 Million USD | 17.42% |
| 2022 | 25.65 Million USD | 15.39% |
| 2021 | 22.23 Million USD | -8.62% |
| 2020 | 24.33 Million USD | 15.56% |
| 2019 | 21.05 Million USD | 22.24% |
| 2018 | 17.22 Million USD | 6.14% |
| 2017 | 16.22 Million USD | 5.22% |
| 2016 | 15.42 Million USD | 8.3% |
| 2015 | 14.24 Million USD | 55.07% |
| 2014 | 9.18 Million USD | 61.12% |
| 2013 | 5.69 Million USD | 37.85% |
| 2012 | 4.13 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 8.38 Million USD | -2.97% |
| 2024 Q1 | 8.63 Million USD | 4.68% |
| 2024 Q3 | 8.4 Million USD | 0.24% |
| 2023 Q2 | 7.22 Million USD | -6.36% |
| 2023 FY | 30.12 Million USD | 17.42% |
| 2023 Q1 | 7.71 Million USD | 10.73% |
| 2023 Q4 | 8.25 Million USD | 19.06% |
| 2023 Q3 | 6.93 Million USD | -4.03% |
| 2022 Q2 | 5.97 Million USD | -5.26% |
| 2022 Q1 | 6.3 Million USD | 2.68% |
| 2022 FY | 25.65 Million USD | 15.39% |
| 2022 Q4 | 6.96 Million USD | 8.67% |
| 2022 Q3 | 6.41 Million USD | 7.32% |
| 2021 Q1 | 5.28 Million USD | -8.69% |
| 2021 Q2 | 5.48 Million USD | 3.84% |
| 2021 FY | 22.23 Million USD | -8.62% |
| 2021 Q3 | 5.31 Million USD | -3.09% |
| 2021 Q4 | 6.14 Million USD | 15.45% |
| 2020 Q3 | 4.95 Million USD | -36.94% |
| 2020 Q4 | 5.78 Million USD | 16.79% |
| 2020 FY | 24.33 Million USD | 15.56% |
| 2020 Q1 | 5.72 Million USD | -3.1% |
| 2020 Q2 | 7.85 Million USD | 37.24% |
| 2019 FY | 21.05 Million USD | 22.24% |
| 2019 Q1 | 4.87 Million USD | 6.83% |
| 2019 Q4 | 5.9 Million USD | 12.01% |
| 2019 Q3 | 5.27 Million USD | 5.7% |
| 2019 Q2 | 4.99 Million USD | 2.37% |
| 2018 Q4 | 4.56 Million USD | 5.17% |
| 2018 Q2 | 3.99 Million USD | -7.83% |
| 2018 Q1 | 4.32 Million USD | 6.5% |
| 2018 FY | 17.22 Million USD | 6.14% |
| 2018 Q3 | 4.33 Million USD | 8.76% |
| 2017 Q2 | 3.96 Million USD | -1.27% |
| 2017 Q4 | 4.06 Million USD | -2.89% |
| 2017 FY | 16.22 Million USD | 5.22% |
| 2017 Q1 | 4.01 Million USD | 26.17% |
| 2017 Q3 | 4.18 Million USD | 5.64% |
| 2016 Q1 | 3.77 Million USD | -4.31% |
| 2016 FY | 15.42 Million USD | 8.3% |
| 2016 Q4 | 3.18 Million USD | -13.41% |
| 2016 Q3 | 3.67 Million USD | -23.3% |
| 2016 Q2 | 4.78 Million USD | 26.81% |
| 2015 Q3 | 3.4 Million USD | -2.66% |
| 2015 Q2 | 3.49 Million USD | 2.78% |
| 2015 Q1 | 3.39 Million USD | 39.34% |
| 2015 FY | 14.24 Million USD | 55.07% |
| 2015 Q4 | 3.94 Million USD | 16.08% |
| 2014 FY | 9.18 Million USD | 61.12% |
| 2014 Q4 | 2.43 Million USD | -0.27% |
| 2014 Q1 | 2.07 Million USD | 16.32% |
| 2014 Q2 | 2.22 Million USD | 6.92% |
| 2014 Q3 | 2.44 Million USD | 10.16% |
| 2013 FY | 5.69 Million USD | 37.85% |
| 2013 Q2 | 1.22 Million USD | -0.38% |
| 2013 Q4 | 1.78 Million USD | 22.78% |
| 2013 Q3 | 1.45 Million USD | 18.45% |
| 2013 Q1 | 1.23 Million USD | 0.0% |
| 2012 FY | 4.13 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 56.57 Million USD | 46.759% |
| BrainsWay Ltd. | 28.01 Million USD | -7.512% |
| Cerus Corporation | 143.15 Million USD | 78.958% |
| Envoy Medical, Inc. | 17.89 Million USD | -68.303% |
| electroCore, Inc. | 32.03 Million USD | 5.957% |
| Helius Medical Technologies, Inc. | 12.48 Million USD | -141.195% |
| IceCure Medical Ltd | 16.87 Million USD | -78.495% |
| Inogen, Inc. | 236.08 Million USD | 87.241% |
| OrthoPediatrics Corp. | 137.01 Million USD | 78.016% |
| Lucid Diagnostics Inc. | 42.43 Million USD | 29.009% |
| Monogram Orthopaedics, Inc. | 17.63 Million USD | -70.832% |
| MaxCyte, Inc. | 84.84 Million USD | 64.497% |
| NeuroOne Medical Technologies Corporation | 12.41 Million USD | -142.696% |
| Nexalin Technology, Inc. | 5.78 Million USD | -421.034% |
| Orthofix Medical Inc. | 667.42 Million USD | 95.487% |
| PAVmed Inc | 64.82 Million USD | 53.534% |
| Rapid Micro Biosystems, Inc. | 51.07 Million USD | 41.026% |
| RxSight, Inc. | 103.85 Million USD | 70.994% |
| Sight Sciences, Inc. | 126.44 Million USD | 76.178% |
| SI-BONE, Inc. | 156.35 Million USD | 80.734% |
| TELA Bio, Inc. | 84.18 Million USD | 64.219% |
| Treace Medical Concepts, Inc. | 203.36 Million USD | 85.188% |
| Vivos Therapeutics, Inc. | 24.94 Million USD | -20.752% |
| Acutus Medical, Inc. | 11.22 Million USD | -168.379% |
| Talis Biomedical Corporation | 67.18 Million USD | 55.165% |
| Spectral AI, Inc. | 20.86 Million USD | -44.377% |
| Nano-X Imaging Ltd. | 55.99 Million USD | 46.206% |
| CVRx, Inc. | 76.14 Million USD | 60.439% |
| DIH Holding US, Inc. Warrants | 3.52 Million USD | -753.822% |
| PetVivo Holdings, Inc. | 11.36 Million USD | -165.145% |
| Bioventus Inc. | 409.91 Million USD | 92.652% |
| Venus Concept Inc. | 80.47 Million USD | 62.569% |
| TriSalus Life Sciences, Inc. | 70.05 Million USD | 57.002% |
| LivaNova PLC | 843.54 Million USD | 96.429% |
| 908 Devices Inc. | 68.08 Million USD | 55.754% |
| Alphatec Holdings, Inc. | 483.59 Million USD | 93.771% |
| Nemaura Medical Inc. | 7.13 Million USD | -321.959% |
| NeuroPace, Inc. | 75.29 Million USD | 59.994% |
| LENSAR, Inc. | 33.33 Million USD | 9.639% |
| Apyx Medical Corporation | 51.01 Million USD | 40.957% |
| Cutera, Inc. | 197.72 Million USD | 84.765% |
| STRATA Skin Sciences, Inc. | 24.78 Million USD | -21.556% |
| BioSig Technologies, Inc. | 28.53 Million USD | -5.583% |
| Anika Therapeutics, Inc. | 191.47 Million USD | 84.268% |
| ClearPoint Neuro, Inc. | 36.06 Million USD | 16.465% |
| Integra LifeSciences Holdings Corporation | 836.39 Million USD | 96.398% |
| Axonics, Inc. | 270.2 Million USD | 88.852% |
| Outset Medical, Inc. | 198.77 Million USD | 84.845% |
| IRIDEX Corporation | 31.81 Million USD | 5.316% |
| PROCEPT BioRobotics Corporation | 180.21 Million USD | 83.285% |
| Tivic Health Systems, Inc. | 8.53 Million USD | -253.057% |
| INVO Bioscience, Inc. | 7.85 Million USD | -283.569% |
| Telesis Bio, Inc. | 63.48 Million USD | 52.554% |
| Viemed Healthcare, Inc. | 98.45 Million USD | 69.404% |
| Varex Imaging Corporation | 224.8 Million USD | 86.6% |
| Quipt Home Medical Corp. | 148.66 Million USD | 79.738% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | -156.955% |
| Pulmonx Corporation | 112.68 Million USD | 73.269% |
| Dynatronics Corporation | 9.9 Million USD | -204.024% |
| Modular Medical, Inc. | 17.52 Million USD | -71.846% |
| ReShape Lifesciences Inc. | 20.18 Million USD | -49.219% |
| Semler Scientific, Inc. | 38.94 Million USD | 22.651% |
| InMode Ltd. | 215.68 Million USD | 86.034% |
| Bruker Corporation | 1.07 Billion USD | 97.202% |
| Cytosorbents Corporation | 48.33 Million USD | 37.681% |
| DexCom, Inc. | 1.69 Billion USD | 98.219% |
| Align Technology, Inc. | 2.07 Billion USD | 98.55% |
| Viveve Medical, Inc. | 22.17 Million USD | -35.854% |
| ZimVie Inc. | 275.12 Million USD | 89.051% |
| Movano Inc. | 29.69 Million USD | -1.458% |
| Cytek Biosciences, Inc. | 137.27 Million USD | 78.056% |
| Nexalin Technology, Inc. | 5.78 Million USD | -421.034% |
| DIH Holdings US, Inc. Class A Common Stock | 3.52 Million USD | -753.822% |
| Tandem Diabetes Care, Inc. | 600.92 Million USD | 94.987% |
| Profound Medical Corp. | 33.6 Million USD | 10.357% |
| Insulet Corporation | 939.9 Million USD | 96.795% |
| enVVeno Medical Corporation | 25.23 Million USD | -19.355% |
| Surmodics, Inc. | 98.69 Million USD | 69.48% |
| iCAD, Inc. | 22.22 Million USD | -35.536% |
| Nuwellis, Inc. | 22.61 Million USD | -33.21% |
| Biotricity, Inc. | 17.18 Million USD | -75.29% |
| iRhythm Technologies, Inc. | 445.88 Million USD | 93.244% |
| Aethlon Medical, Inc. | 12.27 Million USD | -145.349% |
| InspireMD, Inc. | 22.95 Million USD | -31.254% |
| PAVmed Inc. | 64.82 Million USD | 53.534% |
| BIOLASE, Inc. | 34.66 Million USD | 13.093% |
| Beyond Air, Inc. | 61.7 Million USD | 51.179% |
| FONAR Corporation | 28.6 Million USD | -5.307% |
| AxoGen, Inc. | 149.33 Million USD | 79.829% |
| Vivani Medical, Inc. | 26.96 Million USD | -11.711% |
| Tactile Systems Technology, Inc. | 177.09 Million USD | 82.99% |
| Inari Medical, Inc. | 448.59 Million USD | 93.285% |
| UFP Technologies, Inc. | 58.08 Million USD | 48.144% |
| QT Imaging Holdings, Inc. | 4.92 Million USD | -511.308% |
| Heart Test Laboratories, Inc. | 6.31 Million USD | -376.756% |
| Tenon Medical, Inc. | 16.96 Million USD | -77.527% |
| Autonomix Medical, Inc. Common Stock | 7.39 Million USD | -307.45% |
| Co-Diagnostics, Inc. | 44.1 Million USD | 31.699% |
| AdaptHealth Corp. | 1.07 Billion USD | 97.206% |
| Sintx Technologies, Inc. | 15.2 Million USD | -98.163% |
| NanoVibronix, Inc. | 4.97 Million USD | -505.727% |
| Quanterix Corporation | 118.1 Million USD | 74.494% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | -156.955% |
| Sensus Healthcare, Inc. | 14.44 Million USD | -108.578% |
| Pacific Biosciences of California, Inc. | 392.66 Million USD | 92.329% |
| TransMedics Group, Inc. | 182.82 Million USD | 83.523% |
| ReWalk Robotics Ltd. | 28.06 Million USD | -7.332% |
| NeuroMetrix, Inc. | 11.09 Million USD | -171.403% |
| Hyperfine, Inc. | 52.87 Million USD | 43.027% |
| Establishment Labs Holdings Inc. | 172 Million USD | 82.487% |
| Biomerica, Inc. | 6.97 Million USD | -331.683% |
| Bone Biologics Corporation | 9.42 Million USD | -219.493% |
| AVITA Medical, Inc. | 80.77 Million USD | 62.71% |
| Bluejay Diagnostics, Inc. | 10.31 Million USD | -192.136% |
| Silk Road Medical, Inc | 186.35 Million USD | 83.836% |